Morin D, Zini R, Urien S, Sapena R, Tillement J P
Département de Pharmacologie, Faculté de Médecine de Paris XII, Creteil, France.
J Recept Res. 1992;12(3):369-87. doi: 10.3109/10799899209074801.
Binding of (125I)iodocyanopindolol (ICYP) and (3H)CGP-12177 to rat brain homogenates was characterized and compared. ICYP was shown to bind to both beta-adrenergic and serotonin1B (5HT1B) receptors whereas (3H)CGP-12177 only labelled the first ones. The addition of 10 microM serotonin (5HT) prevented ICYP binding to 5HT receptors and under these experimental conditions both ligands labelled a similar total number of beta-adrenoceptors in the different rat brain regions. ICYP displayed a higher affinity for cerebellar (mainly beta 2-subtype) than for cerebral cortex beta-adrenoceptors (mainly beta 1-subtype) suggesting a subtype selectivity. A multiple displacement binding approach using CGP-20712A, a beta 1-subtype ligand, as competitor revealed a 2.6 fold selectivity of ICYP for the beta 2-adrenoceptor subtype. On the other hand, (3H)CGP-12177 binds only to beta-adrenoceptors and is not subtype selective in the rat brain homogenate. Considering both its high specificity and its lack of subtype selectivity (3H)CGP-12177 seems to be a more suitable ligand than ICYP to non-selectively label beta-adrenoceptors in rat brain.
对(125I)碘氰吲哚洛尔(ICYP)和(3H)CGP - 12177与大鼠脑匀浆的结合特性进行了表征和比较。结果表明,ICYP既能与β - 肾上腺素能受体结合,也能与5 - 羟色胺1B(5HT1B)受体结合,而(3H)CGP - 12177仅标记前者。加入10微摩尔5 - 羟色胺(5HT)可阻止ICYP与5HT受体结合,在这些实验条件下,两种配体在不同大鼠脑区标记的β - 肾上腺素能受体总数相似。ICYP对小脑β - 肾上腺素能受体(主要是β2亚型)的亲和力高于大脑皮质β - 肾上腺素能受体(主要是β1亚型),表明具有亚型选择性。使用β1亚型配体CGP - 20712A作为竞争剂的多重置换结合方法显示,ICYP对β2 - 肾上腺素能受体亚型的选择性是2.6倍。另一方面,(3H)CGP - 12177仅与β - 肾上腺素能受体结合,在大鼠脑匀浆中不具有亚型选择性。考虑到(3H)CGP - 12177具有高特异性且缺乏亚型选择性,它似乎比ICYP更适合作为非选择性标记大鼠脑中β - 肾上腺素能受体的配体。